UCSF Lung Transplant Clinic in RosevilleUCSF Lung Transplant Clinic in Roseville
Race-Based Equations May Lead to Under-Treatment of Lung Disease in Black PatientsUsing race-based equations to evaluate lung disease -- a practice promoted in the 2019 guidelines of the American Thoracic Society -- may mean that severe lung disease in Black patients is classified as moderate disease, according to a UCSF-led study.
Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology ProgramPrescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UC San Francisco’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Prescott will assume the role of chief on July 1.
New Research on Cell Regeneration Shows Promise for Treating Lung Injury and FibrosisIn a new study, UCSF researchers showed that they could successfully redirect profibrotic murine lung cells to a nonfibrotic state in which they regenerated alveoli. These findings could lead to novel treatments for lung injury and fibrosis.
UCSF Lung Transplant Patient No. 1,000 Looks Ahead to More of the Good LifeHospital Innovations Boost 3-Year Survival From 50% in 2001 to 90% 20 Years Later
UCSF-led Study Uncovers Unique Stem Cell Trajectory in Lungs Damaged by COVID-19 and Pulmonary FibrosisIn a collaborative study between UCSF researchers appearing December 30 in Nature Cell Biology, UCSF researchers Jaymin Kathiriya, PhD, and Chaoqun Wang, PhD, discovered that severe lung injuries can trigger lung stem cells to undergo abnormal differentiation. Drs. Kathiriya and Wang, supervised by Hal Chapman, MD, and Tien Peng, MD, respectively, utilized stem cell organoid models to uncover a novel stem cell pathway that is seen in severely injured lungs from COVID-19 and idiopathic pulmonary fibrosis patients.
Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary FibrosisResearchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control and mice with pulmonary fibrosis had decreased lung fibrosis and increased survival.
UCSF Post-COVID Clinic Treats Long HaulersUC San Francisco’s OPTIMAL Clinic (pOst-covid-19/PosT-Icu MultidisciplinAry cLinic) is one of the first clinics in the country established to provide follow-up care for patients who have recovered from COVID-19. The clinic’s goal is to optimize patient recovery through a centralized resource designed to coordinate with primary care services.
Lung Transplant Outcomes at UCSF Among the Nation’s BestFor nine consecutive years, the UCSan FranciscoLung Transplant Program has achieved significantly higher-than-expected survival rates following transplant surgery. It is the only lung transplant program in the country with this record.
UCSF MD Link: Web-Based Communication Portal for PhysiciansOur web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.
Virtual Monitoring for Lung Transplant Patients Aided by Home Spirometry DeviceA new home spirometry kit combines a spirometer with a patient engagement platform to collect lung function data and symptoms remotely. This enables UCSF’s Lung Transplant team to remotely track patients with the goal of identifying both symptomatic and asymptomatic changes in lung function that may be the first sign of early chronic rejection.
Lung Transplant ProgramFor nine consecutive years, the UCSF Lung Transplant Program has had significantly higher-than-expected post-surgery survival rates — the only program in the country with this record.